Suppr超能文献

抗菌肽:应对抗菌耐药性的一种有前景的治疗策略。

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance.

作者信息

Nuti Ramya, Goud Nerella S, Saraswati A Prasanth, Alvala Ravi, Alvala Mallika

机构信息

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.

G. Pullareddy College of Pharmacy, Hyderabad, India.

出版信息

Curr Med Chem. 2017;24(38):4303-4314. doi: 10.2174/0929867324666170815102441.

Abstract

BACKGROUND

Antimicrobial resistance (AMR) has posed a serious threat to global public health and it requires immediate action, preferably long term. Current drug therapies have failed to curb this menace due to the ability of microbes to circumvent the mechanisms through which the drugs act. From the drug discovery point of view, the majority of drugs currently employed for antimicrobial therapy are small molecules. Recent trends reveal a surge in the use of peptides as drug candidates as they offer remarkable advantages over small molecules.

METHODS

Newer synthetic strategies like organometalic complexes, Peptide-polymer conjugates, solid phase, liquid phase and recombinant DNA technology encouraging the use of peptides as therapeutic agents with a host of chemical functions, and tailored for specific applications. In the last decade, many peptide based drugs have been successfully approved by the Food and Drug Administration (FDA). This success can be attributed to their high specificity, selectivity and efficacy, high penetrability into the tissues, less immunogenicity and less tissue accumulation. Considering the enormity of AMR, the use of Antimicrobial Peptides (AMPs) can be a viable alternative to current therapeutics strategies. AMPs are naturally abundant allowing synthetic chemists to develop semi-synthetics peptide molecules. AMPs have a broad spectrum of activity towards microbes and they possess the ability to bypass the resistance induction mechanisms of microbes.

RESULT

The present review focuses on the potential applications of AMPs against various microbial disorders and their future prospects. Several resistance mechanisms and their strategies have also been discussed to highlight the importance in the current scenario.

CONCLUSION

Breakthroughs in AMP designing, peptide synthesis and biotechnology have shown promise in tackling this challenge and has revived the interest of using AMPs as an important weapon in fighting AMR.

摘要

背景

抗菌药物耐药性(AMR)对全球公共卫生构成了严重威胁,需要立即采取行动,最好是长期行动。由于微生物能够规避药物的作用机制,目前的药物疗法未能遏制这一威胁。从药物发现的角度来看,目前用于抗菌治疗的大多数药物都是小分子。最近的趋势显示,肽作为候选药物的使用激增,因为它们相对于小分子具有显著优势。

方法

诸如有机金属络合物、肽-聚合物共轭物、固相、液相和重组DNA技术等新的合成策略鼓励使用具有多种化学功能的肽作为治疗剂,并针对特定应用进行定制。在过去十年中,许多基于肽的药物已成功获得美国食品药品监督管理局(FDA)的批准。这一成功可归因于它们的高特异性、选择性和疗效、高组织渗透性、低免疫原性和低组织蓄积性。考虑到AMR的严重性,使用抗菌肽(AMPs)可能是当前治疗策略的可行替代方案。AMPs天然丰富,使合成化学家能够开发半合成肽分子。AMPs对微生物具有广泛的活性,并且它们具有绕过微生物耐药诱导机制的能力。

结果

本综述重点关注AMPs在对抗各种微生物疾病方面的潜在应用及其未来前景。还讨论了几种耐药机制及其策略,以突出当前情况下的重要性。

结论

AMPs设计、肽合成和生物技术方面的突破在应对这一挑战方面显示出了前景,并重新激发了将AMPs用作对抗AMR的重要武器的兴趣。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验